Journal of the American Chemical Society
Communication
The product has an octahedral structure with the four NHC
ligands arranged in a pinwheel-like fashion in the equatorial
plane (Figure 4), a coordination mode that has been observed
Figure 5. Molecular structure of 8. H atoms have been omitted for
clarity. Selected bond lengths (Å): Re−C1, 2.07(3); Re−C3, 2.15(4);
Re−C72, 2.24(3); Re−C56, 2.19(3); Re−C26, 2.45(4).
Figure 4. Molecular structure of 7. H atoms have been omitted for
clarity. Selected bond lengths (Å) and angles (deg): Tc−C1, 2.207(4);
N−Tc−Cl, 180.0; C1−Tc−C1′, 88.8(1).
In conclusion, previously unreported air-stable technetium
complexes with phenyl and triazolylidene ligands have been
synthesized, closing the last gap in the aryl chemistry of
transition metals. Both the aryl and triazolylidene complexes
show interesting reactivities and open new perspectives for the
synthesis of stable organometallic technetium complexes. The
chemistry of technetium with triazolylidenes does not resemble
that of rhenium, which should be subject of further studies.
previously for other technetium imidazolylidene complexes.5
The occupation of the axial coordination positions (i.e., the
{NTc−Cl}+ unit) is disordered along the fourfold axis of the
tetragonal structure (space group P4nc). This required a
refinement of the Cl and N atoms on shared positions, making
the bond lengths on this axis less reliable. Details of the
refinement model are given in the Supporting Information.
Another type of disorder concerns the Cl− counterions, which
are situated in channels formed by the large complex molecules
on another fourfold axis parallel to the metal core. The Tc−C
bond lengths are unexceptional with respect to other
imidazolylidene technetium complexes.5
ASSOCIATED CONTENT
* Supporting Information
■
S
Experimental procedures, characterization data, and crystallo-
graphic details for compounds 1, 2, 4, 5, 7, and 8 (CIF). This
material is available free of charge via the Internet at http://
Treatment of 3 with LMe in benzene results in the exclusive
substitution of the chloro ligand and the formation of the first
transition-metal complex containing imidazolylidene together
with triazolylidene ligands. NMR or mass spectra of [ReN-
(LMe)(LPh)2] (8) could not be recorded because of the low
solubility of 8 in inert solvents. In CDCl3, in which the
compound is readily soluble, it rapidly decomposes via
formation of a paramagnetic species, most probably a ReIV
complex, which exhibits a broad EPR line at a g value of 2.031
without any hyperfine structure. Single crystals of 8 could be
obtained by crystallization from a large amount of MeCN.
Unfortunately, even the best data set obtained from our X-ray
diffraction studies was of low quality (R value of 14.4%). Thus,
the resulting bond lengths and angles are accordingly
characterized by comparably large standard deviations and
should not be overvalued. Only a structural sketch without
ellipsoids is given in Figure 5. All of the main structural features
of the compound, however, can certainly be derived from the
structural analysis. The most interesting feature of 8 is the
orthometalation of the second HLPh ligand (which was
monodentate in 3) trans to the nitrido ligand. Such a structural
feature is without precedent and indirectly confirms the
presence of agostic interactions in [ReNX(HLPh)(LPh)]
complexes (X = halide, pseudohalide, thiolate), as recently
postulated on the basis of crystal structure data.12b
AUTHOR INFORMATION
Corresponding Author
■
Present Address
†ANSTO Life Sciences, Locked Bag 2001, Kirrawee DC, NSW
2232, Australia (E.O.).
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
We thank Dr. Adelheid Hagenbach for valuable help with
crystallographic problems.
■
REFERENCES
■
(1) Sattelberger, A. P.; Scott, B. L. Technetium. In Comprehensive
Organometallic Chemistry III; Crabtree, R., Mingos, D. M. P., Eds.;
Elsevier: Oxford, U.K., 2007; Vol. 5, p 833.
(2) Cambridge Crystal Structure Database, version 5.30; Cambridge
Crystallographic Data Centre: Cambridge, U.K., 2008.
(3) Jones, A. G.; Abrams, M. J.; Davison, A.; Brodack, J. W.;
Toothaker, A. K.; Adelstein, S. J.; Kassis, A. I. Nucl. Med. Biol. 1984, 11,
225.
(4) (a) Alberto, R.; Schibli, R.; Schubiger, P. A. Polyhedron 1996, 15,
1079. (b) Alberto, R.; Schibli, R.; Egli, A.; Abram, U.; Kaden, T. A.;
Schubiger, P. A. J. Am. Chem. Soc. 1998, 120, 7987. (c) Alberto, R.;
9120
dx.doi.org/10.1021/ja3033718 | J. Am. Chem. Soc. 2012, 134, 9118−9121